Jo Vandercappellen
Impact in
- Oncology top 5%
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
-
- Cell Adhesion Molecules Research 5
-
- Multiple Sclerosis Research Studies 6
- Co-authors
- Sofie Struyf (8 shared papers)Jo Van Damme (8 shared papers)Paul Proost (5 shared papers)Mieke Gouwy (4 shared papers)Marc Parmentier (2 shared papers)Ghislain Opdenakker (4 shared papers)Evemie Schutyser (3 shared papers)Sam Noppen (4 shared papers)
- Journals
- Neurology and Therapy (2 papers)Blood (2 papers)Mycoses (1 paper)European Journal of Immunology (1 paper)Molecular Cancer Research (1 paper)
- Partner nations
- BelgiumItalyUnited States
In The Last Decade
Jo Vandercappellen
17 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Oncology 639
- Immunology 493
- Immunology and Allergy 78
- Cancer Research 95
- Hematology 64
Countries citing papers authored by Jo Vandercappellen
This map shows the geographic impact of Jo Vandercappellen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Vandercappellen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Vandercappellen more than expected).
Fields of papers citing papers by Jo Vandercappellen
This network shows the impact of papers produced by Jo Vandercappellen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Vandercappellen. The network helps show where Jo Vandercappellen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jo Vandercappellen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 545 | |
| 2 | 2010 | 144 | |
| 3 | 2007 | 116 | |
| 4 | 2010 | 93 | |
| 5 | 2009 | 61 | |
| 6 | 2010 | 37 | |
| 7 | 2007 | 28 | |
| 8 | 2009 | 27 | |
| 9 | 2010 | 22 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 7 | |
| 14 | 2025 | 6 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | Involvement of lipid rafts in antifungal mode of action of miconazole | 2005 | 1 |
| 18 | 2024 | 0 |
About Jo Vandercappellen
Jo Vandercappellen is a scholar working on Immunology and Allergy, Pathology and Forensic Medicine, Oncology, Hematology and Geriatrics and Gerontology, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (7 papers), Multiple Sclerosis Research Studies (6 papers), Cell Adhesion Molecules Research (5 papers), Angiogenesis and VEGF in Cancer (3 papers), Multiple Myeloma Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Glycosylation and Glycoproteins Research (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Oncology (639 citations), Immunology (493 citations), Immunology and Allergy (78 citations), Cancer Research (95 citations) and Hematology (64 citations). Jo Vandercappellen has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Sofie Struyf, Jo Van Damme, Paul Proost, Mieke Gouwy, Marc Parmentier, Ghislain Opdenakker, Evemie Schutyser, Sam Noppen, Isabelle Ronsse and Willy Put. Their work appears in journals such as Neurology and Therapy, Blood, Mycoses, European Journal of Immunology and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.